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Edited by Hans-Dieter KlenkAbstract The Sendai virus ‘‘C-proteins’’ (C 0, C, Y1 and Y2)
are a nested set of non-structural proteins. The shorter Y pro-
teins arise in vivo both by de novo translation initiation and by
proteolytic processing of C 0. In this paper, we demonstrate that
C 0 but not C (diﬀering only by 11 N-terminal amino acid) serves
as an eﬃcient substrate for intracellular processing. However,
processing can be mimicked in vitro by the addition of endopep-
tidases. Under conditions of limited proteolysis we observed that
in a fraction of the C 0 protein the Y region exists as a proteinase
resistant core. This core was conserved in the C protein. We pro-
pose that C 0 functions as a Pro-protein delivering the Y module
to a speciﬁc intracellular location.
 2005 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
Keywords: Protein processing; Translation initiation; Viral
non-structural proteins1. Introduction
The Sendai virus ‘‘C-proteins’’ (C 0, C, Y1 and Y2) represent
a group of viral non-structural proteins that although not
essential for growth in cell culture, play key roles in: (a) mod-
ulating the read-out from the viral genome [1], (b) maintenance
of genomic stability [2], (c) viral particle budding [3], and, (d)
modulating the host cell response during infection [4,5]. They
are expressed from the P/C mRNA that codes for no less than
six diﬀerent polypeptide chains (namely, C 0, P, C, Y1, Y2 and
X) [6,7]. The initiation sites were mapped by in vitro mutagen-
esis [8]. The largest of the four ‘‘C-proteins’’ starts at an ACG
codon at position 81 (ACG81) [9,10], with the others initiating
at AUG114 (C), AUG183 (Y1) and AUG201 (Y2) (Fig. 1A).
Changing ACG81 to AUG (AUG81) ablated all translation
from the second and third sites [9]. Nonetheless, Y expression
continued, suggesting that ribosomes had scanned non-linearly
to these start codons. However, a number of in vivo observa-
tions were diﬃcult to reconcile with a simple initiation model.
Firstly, Y expression was AUG codon independent (an event
not observed in vitro) [8,11,12]. Secondly, deletion mutants
were identiﬁed that signiﬁcantly altered Y expression in a man-Abbreviations: RRL, rabbit reticulocyte lysates; STAT, signal trans-
ducers and activators of transcription; aa, amino acid
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in vitro). In the AUG81 background, deletion of nucleotides
189–197 (D9) increased Y by up to 10-fold. Two mutations se-
verely perturbed Y expression. The ﬁrst deleted 24 nts down-
stream of the Y2 start codon (D10), whilst the second added
6 amino acid (aa) to the extreme N-terminal of C 0 [11,13].
The Y proteins can arise both via de novo translation initi-
ation from AUG183/AUG201 and also via processing of C 0 [13].
This processing occurs in living cells but not in vitro, reconcil-
ing the conﬂicting in vivo versus in vitro observations. In this
report, we demonstrate that processing can be mimicked
in vitro using endoproteinases suggesting that Y represents a
proteinase resistant core. Curiously, this core also exists in
the shorter C protein even though it does not serve as an eﬃ-
cient processing substrate in cells. We propose that this failure
to process C is linked to its diﬀerent intracellular location.2. Materials and methods
2.1. DNA constructions
Constructs AUG81, C0D9, C0D9YCys (Y start codons have been changed
to UGU), C0D10, C0D9þ6 (6 aa have been fused to the N terminal of C 0) are
described in [11,13]. The regions fromAUG81=C
0
to AUG183/Y1, AUG114/
C to AUG183/Y1 and AUG81=C
0
to AUG114/C were ampliﬁed by PCR and
substituted into the pEBS-PL AUG81-GFP (C 0-GFP) clone [13] as a
NcoI/XbaI fragment to generate pEBS PL (1–35)-GFP, (12–35)-GFP,
and (1–12)-GFP, respectively (numbers refer to the aa positions in C 0).
2.2. Cell culture, transient transfection and metabolic labelling
Cell culture, transfections, metabolic labelling and pulse chase exper-
iments were performed as previously described in [13].
2.3. In vitro transcription and translation
Run-oﬀ capped transcripts were transcribed with the bacteriophage
T7 RNA polymerase in 800 lM ATP/CTP/UTP, 400 lM GTP and 2
mM m7GpppG cap analogue (Ambion). Capped mRNAs (50 lg/ml)
were translated in a rabbit reticulocyte lysates (RRL) (Promega) in
the presence of 0.5 mMMgOAc, 75 mM KCl, 20 lM aa (minus methi-
onine) and 0.5 mCi/ml of 35S-translabel. The mixture was incubated
for 1 h at 30 C. Translation products were either analysed directly
or immunoprecipitated with an anti-HA monoclonal antibody (Ab
16b12; Eurogentec).
2.4. Limited proteolysis
RNA transcripts from clones coding for AUG81, C0D9YCys, C0D10, Cwt
and C0D9þ6 were translated in a RRL, or transiently expressed in HeLa
cells. Extracts were treated with chymotrypsin at the doses indicated in
the ﬁgures. The proteinase was stopped by the addition of 1% SDS and
heating at 65 C for 5 min. Samples were diluted 10-fold in lysis buﬀer
(150 mM NaCl, 50 mM Tris, pH 7.4, 5 mM EDTA, and 0.5% NP40)
before immunoprecipitating [13].ation of European Biochemical Societies.
Fig. 1. C protein is a poor proteolytic substrate in vivo. (A). Schematic representation of the C ORF in the background AUG81 indicating the
initiation sites. The AUG codon for P is indicated below the line because it is in a diﬀerent ORF. HA refers to the triple HA epitope tag. The position
of the 6 aa N-terminal extension and the sites of the D9 and D10 deletions are also indicated. (B) HeLa cells infected with vaccinia-T7 were transfected
with the clones indicated above the panel. In the mock control, cells were transfected with an empty vector. Cells were labelled with 35S translabel at
18–20 h postinfection. Cytoplasmic extracts were immunoprecipitated with an anti-HA antibody. Immunoselected proteins were resolved on a 15%
SDS–polyacrylamide gel and visualised by ﬂuorography. Bands were quantitated on a phosphorimager and the amount of Y is indicated below the
panel as a percentage of the total protein immunoprecipitated. (C) Transfected HeLa cells expressing C0D9 or CD9 were metabolically labelled with 35S
translabel for 1 h at 18 h postinfection and then chased for the times (min) indicated above the panels. Proteins were immunoselected and analysed.
The results are depicted graphically below the gels.
5686 S. de Breyne et al. / FEBS Letters 579 (2005) 5685–56902.5. Antibodies and indirect immunoﬂuorescence assay
HeLa cells were ﬁxed and permeabilised in 3% formaldehyde/PBS
during 20 min and 0.05% saponin/PBS during 5 min. They were then
washed three times in PBS. The anti-HA mouse antibody was used
at a 1:100 dilution in PBS. Coverslips were incubated with the antibody
for 20 min at room temperature. After three PBS washes, the second-
ary antibody conjugated with alexa-568 (mouse) was added at a dilu-
tion of 1:200, for 20 min at room temperature. Confocal microscopic
analysis was performed on a confocal laser scan ﬂuorescence-inverted
microscope (LSM 410, Zeiss).3. Results
3.1. Y Proteins in vivo do not arise via processing of the C
protein
We tested whether the shorter C protein served as an eﬀec-
tive intracellular processing substrate by applying the criteria
previously employed [13], namely: (a) does the D9 deletion pro-
duce an increase in Y expression, and (b) is Y expression inde-
S. de Breyne et al. / FEBS Letters 579 (2005) 5685–5690 5687pendent of the nature of the Y start codon? Sequences 5 0 to the
C AUG114 initiation codon (nucleotides 1–110) were deleted in
both the wt (referred to as Cwt) and D9 (referred to as CD9)
backgrounds. Furthermore, in Cwt the Y codons were changed
to ACG (CYThr), and in D9 they were changed to UGU
(CD9YCys). Changing the Y start codons to both UGU (Cys)
and ACG (Thr) precludes expression of Y proteins by transla-
tion initiation since it is strictly AUG codon dependent [11,12].
These constructs were expressed in HeLa cells (Fig. 1B). As
controls, AUG81 (expressing C 0, Y1 and Y2; lane 2), C0D9 (lane
7) and C0D9YCys (lane 12) were also expressed. Both Cwt (lanes 3
and 4) and CD9 (lanes 8 and 9) expressed Y proteins (Y1 and
Y2 co-migrate in the D9 background; cf. [11]). However,
changes in Y levels were minor compared to that observed in
the C 0 background (compare lanes 2 and 7). Importantly, Y
expression was largely AUG codon dependent and did not
vary when the codons were either UGU or ACG (compare
lanes 5/6 and 10/11). This failure to observe a marked increase
in Y expression in the CD9Cys clone contrasts with that ob-
served in C0D9YCys (compare lanes 10/11 with lane 12). There-
fore, in a construct that expresses C but not C 0, Y arises
almost exclusively by translational initiation even in the D9
background.
The failure to eﬃciently process Cwt or CD9 to Y could sim-
ply reﬂect an increased stability of these proteins. However,
pulse chase experiments indicted that the CD9 and C0D9 proteins
had very similar half lives (ca. 40 and 50 min, respectively:
Fig. 1C).Fig. 2. Proteolytic processing can be reproduced in vitro with
exogenous endopeptidases. Transcripts from AUG81 (A), C0D9YCys
(B), C0D10 (C) and Cwt (D) were translated in a RRL. Lysates (12 lL)
were treated with diﬀerent concentrations (lg/ml) of chymotrypsin as
indicated for 15 min at 37 C. As a control, no transcript (mock) or
only Y proteins (D5 0Y) were translated. Products were directly
analysed on SDS–PAGE (upper panel: Crude extract) or immunos-
elected with an anti-HA antibody (lower panel: IP HA).3.2. Demonstration of processing in vitro
Y protein expression in RRL is strictly AUG codon depen-
dent [13,14]. We decided to explore the possibility that process-
ing could be mimicked by the addition of exogenous
proteinases. mRNAs encoding AUG81, C0D9YCys, C0D10 (a pro-
cessing defective mutant: [13]) and Cwt were translated. Prod-
ucts were treated with an increasing dose of chymotrypsin
(Fig. 2). The P1-P1 0 Met-Leu dipeptide at both Y1 and Y2
should be cleaved at high frequency. To ensure that processing
had occurred N-terminally, the products were immunoprecip-
itated (all are C-terminally HA-tagged). The AUG81 mRNA
expressed C 0 and small amounts of Y2 (in the RRL Y2 is
the major product as has been conﬁrmed by toeprinting
[13]). Upon proteinase treatment C 0 diminished and a band
co-migrating with Y increased (D5 0Y expresses only the Y pro-
teins and serves as a marker; cf. [13]), suggesting that the pro-
teinase resistant module mapped to this region. At the highest
dose all bands were lost (Fig. 2A). The result was more striking
with C0D9YCys which does not express Y in the RRL (Fig. 2B).
However, treatment of C0D10 did not produce a Y protein sug-
gesting disruption of the proteinase resistant core (Fig. 2C),
whereas Y was observed after treatment of Cwt (Fig. 2D).
In vitro expressed proteins may fold diﬀerently to those in
living cells. We therefore performed analogous proteolytic
structural probing on extracts prepared from transfected HeLa
cells and obtained essentially identical results (Fig. 3). Addi-
tionally, we examined the C0D9þ6 clone (6 aa added at the very
N-terminal of C 0). Although this construct carries the D9 dele-
tion no increase in Y levels is observed in vivo [13]. However,
processing was identical to that observed with C 0 (AUG81;
Fig. 3D). The failure to observe increased Y levels with this
construct is therefore not the consequence of a misfolding(compare with C0D10). Note also that the results with AUG81
(Fig. 3A) suggest that the proteinase resistant core maps to
Y2 rather than Y1 since the latter is rapidly lost during the
treatment.
Therefore, under conditions of limited proteolysis the C 0 and
C proteins can be cleaved to generate Y. Quantiﬁcation indi-
cated that ca. 60% of C 0 or C is rapidly degraded. Since for
a serine proteinase about 12 aas around each scissile bond
must be amenable to conformational change to enter into
the catalytic pocket, combined with the fact that 36 out of
the 43 chymotrypsin sites fall within the Y module, leads us
to propose that this protein fraction is unfolded and therefore
Fig. 3. The D10 mutation perturbs the Y core. Vaccinia-T7-infected HeLa cells were transfected with clones expressing AUG81 (A), C0D10 (B), Cwt
and CD9YCys (C) or C0D9þ6 (D). As controls, empty vector (mock) or a vector expressing only the Y proteins (D5 0Y) were transfected. Cytoplasmic
extracts (ca. 1 lg of protein) were treated with diﬀerent concentrations (lg/ml) of chymotrypsin as indicated above each panel. Products were
immunoselected with an anti-HA antibody and analysed on SDS–PAGE.
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core is in the C protein, why do we not observe C processing
in vivo?
3.3. Amino acids 1–35 can relocalise GFP within the cell
A C 0-GFP fusion protein (aa 1–215) and a C-GFP fusion (aa
12–215) localise diﬀerently in the cell [13]. We decided to exam-
ine to what extent this redistribution of the GFP could be
attributed to aa speciﬁc to C 0. Constructs were generated in
which aa 1–35, 1–12 and 12–35 were fused N-terminally to
GFP, and these were co-expressed with a HA-tagged form of
C 0 (C0HA). As controls we examined the co-expression of
½GFPþ C0HA and ½C0-GFPþ C0HA (Fig. 4) because it has been
reported that GFP fusions can localise aberrantly [16]. GFP
alone was distributed throughout the cell with an intense nu-
clear staining. In contrast, C0HA was exclusively cytoplasmic.
This may reﬂect the proteins capacity to interact with the sig-
nal transducer and activator of transcription 1 (STAT1)
[17,18]. Co-expression of ½C0-GFPþ C0HA produced consider-
able, but incomplete, co-localisation throughout the cyto-
plasm. An essentially identical proﬁle was observed in cells
co-expressing ½ð1–35Þ-GFPþ C0HA. In cells expressing
½ð1–12Þ-GFPþ C0HA the GFP showed a strong nuclear stain-
ing similar to that observed in the control ½GFPþ C0HA. TheGFP in cells expressing ½ð12–35Þ-GFPþ C0HA was detected
throughout the cell, and co-localisation with C0HA was most
pronounced at the plasma membrane. It has been reported
that the N-terminal end of the C protein is involved in an inter-
feron independent STAT1 interaction [19]. This result would
suggest that aa 12–35 are suﬃcient for this interaction.4. Discussion
The Y proteins arise both by translation initiation, and by
intracellular processing of the C 0 protein [11–13]. This genera-
tion of the same polypeptide both by initiation and processing
is not unique. The CCAAT/enhancer binding protein b (C/
EBPb) exists as an N-terminal nested set of four isoforms: full
length 38 kDa C/EBPb, 35 kDa LAP (liver enriched transcrip-
tional activator protein), 21 kDa LIP (liver enriched transcrip-
tional inhibitor protein), and a 14 kDa form. The negative
regulator LIP can be generated either by initiation on the third
AUG of the C/EBPbmRNA, or by a speciﬁc proteolytic cleav-
age of the full length C/EBPb [20,21].
Based upon the neural network programme PONDR (pre-
dictor of natural disordered regions), the ‘‘C-proteins’’ are pre-
dicted to belong to a class of proteins referred to as natively
Fig. 4. Amino acid sequence between AUG81C
0
to AUG181Y1 exhibits a speciﬁc intracellular localisation. HeLa cells were co-transfected with pEBS-
PL C0HA (all panels) and either, pEBS PL GFP (A), pEBS-PL C 0-GFP (B), pEBS PL (1–35)-GFP (C), pEBS PL (12–35)-GFP (D) or pEBS PL (1–12)-
GFP (E). Images were recorded by confocal microscopy. The central panels correspond to images obtained with the red ﬁlte, and the right hand
panels to those obtained with the green ﬁlter. The panels on the left represent merged images. The overlap of signals results in a yellow colour.
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protein is characterised by its sensitivity to proteinase degrada-
tion in vitro [22,26]. Natively unfolded proteins undergo a dis-
ordered/ordered transition (‘‘induced folding’’) upon
interaction with their ligands, a property ideally suited to pro-
teins that interact with multiple targets. The strong predictions
for disorder in the ‘‘C-proteins’’ would therefore be consistent
with their multiply functions. It was therefore surprising to dis-
cover that a fraction (30–40%) of the intracellular C 0 and C
proteins have a proteinase resistant core mapping to Y,
whereas the majority is rapidly degraded, consistent with an
unfolded structure. This suggests two intracellular pools of
C 0/C proteins distinguished by their folding.
The nature of the intracellular proteinase that processes C 0
remains elusive. Pharmacological approaches, exploiting arange of membrane permeable proteinase inhibitors, failed to
perturb Y levels (data not shown). However, a somewhat anal-
ogous situation has been described for the amyloid adaptor
protein p97FE65. Like C 0, this protein interacts with a number
of cellular partners including the tail of the b-amyloid precur-
sor protein (APP). It is also proteolytically processed at its N-
terminus to generate p65FE65, a form of the protein that
exhibits enhanced aﬃnity for APP. Cleavage could not be
inhibited in vivo using a range of inhibitors, and became inac-
tive once cells were lysed [23].
In an earlier study we observed that C 0-GFP (aa 1–215) and
C-GFP (aa 12–215) fusion proteins showed altered intracellu-
lar distributions. This has been extended by the demonstration
that the aa between C 0 and Y (1–35) but not those between C
and Y (12–35) could induce a redistribution of GFP essentially
5690 S. de Breyne et al. / FEBS Letters 579 (2005) 5685–5690identical to that observed with C 0-GFP. The intracellular com-
partment targeted by this signal remains to be identiﬁed.
Nonetheless, given that to date no major functional diﬀerences
have been reported between the C 0 and C proteins and that
most of the functional domains are located within the Y pro-
tein [5], this observation opens the possibility that C 0 may serve
as a Pro-protein whose role is to deliver Y to a speciﬁc intra-
cellular site.
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